PlumX Metrics
Embed PlumX Metrics

Genotypes Influence Clinical Progression in EYS-Associated Retinitis Pigmentosa

Translational Vision Science and Technology, ISSN: 2164-2591, Vol: 11, Issue: 7, Page: 6
2022
  • 5
    Citations
  • 0
    Usage
  • 11
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Purpose: The purpose of this study was to investigate the genetic and clinical characteristics of eyes shut homolog (EYS)-associated retinitis pigmentosa (RP). Methods: This was a retrospective cross-sectional observational study of 36 patients with EYS-associated autosomal recessive RP (arRP). Results: The gene sequencing results revealed that c.6416G>A (p.Cys2139Tyr) and c.7228+1G>A were the two most predominant variants in our cohort and that variants near the C-terminus, which contains alternating laminin and epidermal growth factor (EGF) domains, accounted for the majority of the allele counts (58 of a total of 72) and relative allele frequencies (81%). Over half of the patients presented with pericentral-type RP (n = 19, 60%), which frequently occurred in combination with macular lesions (n = 10, 52%). Patients having both variants within the alternating laminin and EGF domains near the C-terminus had a more severe disease progression (average 0.045 logMAR increase per year) than those having one variant in the N-terminus and the other in the C-terminus (average 0.001 logMAR increase per year). Conclusions: Pericentral RP was the major phenotype in patients with EYS-associated arRP. There was also a statistically significant relationship between the location of the variants and the severity of the disease. Translational Relevance: This study may aid patients with EYS-associated arRP to predict future vision acuity based on their genetic and clinical features.

Bibliographic Details

Lo, Jui-En; Cheng, Chia-Yi; Yang, Chang-Hao; Yang, Chung-May; Chen, Yi-Chieh; Huang, Yu-Shu; Chen, Pei-Lung; Chen, Ta-Ching

Association for Research in Vision and Ophthalmology (ARVO)

Engineering; Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know